Healthcare >> Analyst Interviews >> June 2, 2002
Carolyn Pratt, a Biotech Analyst at Needham & Company, joined the
company in 1999 to cover biotechnology and life sciences. She previously
worked in the Biotechnology Equity Research Group at Montgomery
Securities, now Banc of America Securities. From 1987 to 1997, she
worked at Genetics Institute, Inc., now part of American Home Products.
Prior to Genetics Institute, from 1982 to 1997, she worked at Ortho
Pharmaceutical Corporation and Ortho Biotech, both divisions of Johnson
& Johnson. She has a degree in Pharmacy. Profile
take to investing in biotechnology, and the characteristics of the
companies that you focus on most closely?
Ms. Pratt:
